Biologic Drugs Market By Therapeutic Protein, Monoclonal Antibody and Vaccine - Global Industry Analysis And Forecast To 2025

Published On : December 2018 Pages : 170 Category: Pharmaceuticals Report Code : HC122195

Biologic Drugs Market By Therapeutic Protein (Betaseron, Levemir, Aranesp, Humalog, Neulasta, Epogen, Neupogen, Eylea, Avonex, Rebif, Enbrel, Victoza, Lantus and NovoLog); Monoclonal Antibody (Remicade, Humira, Avastin, Lucentis, Herceptin and Rituxan) and Vaccine (Varivax, Fluzone, Gardasil, Cervarix and Prenvar 13) - Global Industry Analysis And Forecast To 2025          

Industry Outlook

Biologic Drugs are the drugs made up of complex molecules produced from the living microorganisms, plants or animal cells. Numbers of Biologic Drugs are manufactured using recombinant DNA technique. They are sometimes referred to as Biopharmaceuticals. Biologic Drugs are a revolutionized way of treatment for many serious and prolonged diseases, they have pushed down the small-molecule drugs from top rank. Disorders like Rheumatoid arthritis, certain cancers, and diabetes have more number of Biologic treatments. Biologic Drugs use is growing due to factors like; headway in biomedical science and advancement in novel biological products, rising use of Biologic Drugs in treatment of various disorders, rise in the number of aged people, increasing spread og knowledge about Biologic Drugs by different private and public organizations, technical development & increase in on-going R&D, etc. Therefore, the Biologic Drugs Market is anticipated to expand and has tremendous scope during the forecast period. The global Biologic Drugs Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Biologic Drugs Market is based on segment, by Therapeutic Protein the market is segmented into Betaseron, Levemir, Aranesp, Humalog, Neulasta, Epogen, Neupogen, Eylea, Avonex, Rebif, Enbrel, Victoza, Lantus and NovoLog; by Monoclonal Antibody the market is segmented into Remicade, Humira, Avastin, Lucentis, Herceptin and Rituxan; and by Vaccine the market is segmented into Varivax, Fluzone, Gardasil, Cervarix and Prenvar 13.

  • Biologic Drugs Market, By Therapeutic Protein
  • Betaseron
  • Levemir
  • Aranesp
  • Humalog
  • Neulasta
  • Epogen
  • Neupogen
  • Eylea
  • Avonex
  • Rebif
  • Enbrel
  • Victoza
  • Lantus
  • NovoLog
  • Biologic Drugs Market, By Monoclonal Antibody
  • Remicade
  • Humira
  • Avastin
  • Lucentis
  • Herceptin
  • Rituxan
  • Biologic Drugs Market, By Vaccine
  • Varivax
  • Fluzone
  • Gardasil
  • Cervarix
  • Prenvar 13

Regional Insights

On a global front, the Biologic Drugs Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the global Biologic Drugs Market.

Biologic Drugs Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc., Bristol-Myers Squibb Co., Biogen Idec, Eli Lilly and Co., Merck & Co. Inc., Novartis AG, Amgen Inc. and Baxter International Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Abbott Laboratories
  • Pfizer Inc.
  • GlaxoSmithKline Plc.
  • Bristol-Myers Squibb Co.
  • Biogen Idec
  • Eli Lilly and Co.
  • Merck & Co. Inc.
  • Novartis AG
  • Amgen Inc.
  • Baxter International Inc.

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Biologic Drugs Market, By Therapeutic Protein, Estimates and Forecast, 2014-2025 ($Million)

o   Betaseron

o   Levemir

o   Aranesp

o   Humalog

o   Neulasta

o   Epogen

o   Neupogen

o   Eylea

o   Avonex

o   Rebif

o   Enbrel

o   Victoza

o   Lantus

o   NovoLog

o   Biologic Drugs Market, By Monoclonal Antibody, Estimates and Forecast, 2014-2025 ($Million)

o   Remicade

o   Humira

o   Avastin

o   Lucentis

o   Herceptin

o   Rituxan

o   Biologic Drugs Market, By Vaccine, Estimates and Forecast, 2014-2025 ($Million)

o   Varivax

o   Fluzone

o   Gardasil

o   Cervarix

o   Prenvar 13

o   Biologic Drugs Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Biologic Drugs Market, By Country

o   U.S. Biologic Drugs Market

o   Canada Biologic Drugs Market

o   Mexico Biologic Drugs Market

o   Europe

§  Europe Biologic Drugs Market, By Country

o   Germany Biologic Drugs Market

o   UK Biologic Drugs Market

o   France Biologic Drugs Market

o   Russia Biologic Drugs Market

o   Italy Biologic Drugs Market

o   Rest of Europe Biologic Drugs Market

o   Asia-Pacific

§  Asia-Pacific Biologic Drugs Market, By Country

o   China Biologic Drugs Market

o   Japan Biologic Drugs Market

o   South Korea  Biologic Drugs Market

o   India Biologic Drugs Market

o   Southeast Asia Biologic Drugs Market

o   Rest of Asia-Pacific Biologic Drugs Market

o   South America

§  South America Biologic Drugs Market, By Country

o   Brazil Biologic Drugs Market

o   Argentina Biologic Drugs Market

o   Columbia Biologic Drugs Market

o   Rest of South America Biologic Drugs Market

o   Middle East and Africa

§  Middle East and Africa Biologic Drugs Market, By Country

o   Saudi Arabia Biologic Drugs Market

o   UAE Biologic Drugs Market

o   Egypt Biologic Drugs Market

o   Nigeria Biologic Drugs Market

o   South Africa Biologic Drugs Market

o   Rest of MEA Biologic Drugs Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Biologic Drugs Market, By Therapeutic Protein

5.1.     Introduction

5.2.     Global Biologic Drugs Revenue and Market Share by Therapeutic Protein (2014-2018)

5.2.1.  Global Biologic Drugs Revenue and Revenue Share by Therapeutic Protein (2014-2018)

5.3.     Betaseron

5.3.1.  Global Betaseron Revenue and Growth Rate (2014-2018)

5.4.     Levemir

5.4.1.  Global Levemir Revenue and Growth Rate (2014-2018)

5.5.     Aranesp

5.5.1.  Global Aranesp Revenue and Growth Rate (2014-2018)

5.6.     Humalog

5.6.1.  Global Humalog Revenue and Growth Rate (2014-2018)

5.7.     Neulasta

5.7.1.  Global Neulasta Revenue and Growth Rate (2014-2018)

5.8.     Epogen

5.8.1.  Global Epogen Revenue and Growth Rate (2014-2018)

5.9.     Neupogen

5.9.1.  Global Neupogen Revenue and Growth Rate (2014-2018)

5.10. Eylea

5.10.1.      Global Eylea Revenue and Growth Rate (2014-2018)

5.11. Avonex

5.11.1.      Global Avonex Revenue and Growth Rate (2014-2018)

5.12. Rebif

5.12.1.      Global Rebif Revenue and Growth Rate (2014-2018)

5.13. Enbrel

5.13.1.      Global Enbrel Revenue and Growth Rate (2014-2018)

5.14. Victoza

5.14.1.      Global Victoza Revenue and Growth Rate (2014-2018)

5.15. Lantus

5.15.1.      Global Lantus  Revenue and Growth Rate (2014-2018)

5.16. NovoLog

5.16.1.      Global NovoLog Revenue and Growth Rate (2014-2018)

6.       Biologic Drugs Market, By Monoclonal Antibody

6.1.     Introduction

6.2.     Global Biologic Drugs Revenue and Market Share by Monoclonal Antibody (2014-2018)

6.2.1.  Global Biologic Drugs Revenue and Revenue Share by Monoclonal Antibody (2014-2018)

6.3.     Remicade

6.3.1.  Global Remicade Revenue and Growth Rate (2014-2018)

6.4.     Humira

6.4.1.  Global Humira Revenue and Growth Rate (2014-2018)

6.5.     Avastin

6.5.1.  Global Avastin Revenue and Growth Rate (2014-2018)

6.6.     Lucentis

6.6.1.  Global Lucentis Revenue and Growth Rate (2014-2018)

6.7.     Herceptin

6.7.1.  Global Herceptin  Revenue and Growth Rate (2014-2018)

6.8.     Rituxan

6.8.1.  Global Rituxan Revenue and Growth Rate (2014-2018)

7.       Biologic Drugs Market, By Vaccine

7.1.     Introduction

7.2.     Global Biologic Drugs Revenue and Market Share by Vaccine  (2014-2018)

7.2.1.  Global Biologic Drugs Revenue and Revenue Share by Vaccine  (2014-2018)

7.3.     Varivax

7.3.1.  Global Varivax Revenue and Growth Rate (2014-2018)

7.4.     Fluzone

7.4.1.  Global Fluzone Revenue and Growth Rate (2014-2018)

7.5.     Gardasil

7.5.1.  Global Gardasil Revenue and Growth Rate (2014-2018)

7.6.     Cervarix

7.6.1.  Global Cervarix  Revenue and Growth Rate (2014-2018)

7.7.     Prenvar 13

7.7.1.  Global Prenvar 13 Revenue and Growth Rate (2014-2018)

8.       Biologic Drugs Market, By Region

8.1.     Introduction

8.2.     Global Biologic Drugs Revenue and Market Share by Regions

8.2.1.  Global Biologic Drugs Revenue by Regions (2014-2018)

8.3.     North America Biologic Drugs by Countries

8.3.1.  North America Biologic Drugs Revenue and Growth Rate (2014-2018)

8.3.2.  North America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Biologic Drugs by Countries

8.4.1.  Europe Biologic Drugs Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Biologic Drugs by Countries

8.5.1.  Asia-Pacific Biologic Drugs Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Biologic Drugs by Countries

8.6.1.  South America Biologic Drugs Revenue and Growth Rate (2014-2018)

8.6.2.  South America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Biologic Drugs by Countries

8.7.1.  Middle East and Africa Biologic Drugs Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Biologic Drugs Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Abbott Laboratories

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Pfizer Inc.

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     GlaxoSmithKline Plc.

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Bristol-Myers Squibb Co.

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Biogen Idec

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Eli Lilly and Co.

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Merck & Co. Inc.

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     Novartis AG

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Amgen Inc.

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

9.10. Baxter International Inc.

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.       Revenue and Market Share

10.    Global Biologic Drugs Market Competition, by Manufacturer

10.1. Global Biologic Drugs Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Biologic Drugs Price By Region (2016-2017)

10.3. Top 5 Biologic Drugs Manufacturer Market Share

10.4. Market Competition Trend

11.    Biologic Drugs Market Forecast (2018-2025)

11.1. Global Biologic Drugs Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Biologic Drugs Market Forecast by Regions (2018-2025)

11.2.1.      North America Biologic Drugs Market Forecast (2018-2025)

11.2.1.1. United States Biologic Drugs Market Forecast (2018-2025)

11.2.1.2. Canada Biologic Drugs Market Forecast (2018-2025)

11.2.1.3. Mexico Biologic Drugs Market Forecast (2018-2025)

11.2.2.      Europe Biologic Drugs Market Forecast (2018-2025)

11.2.2.1. Germany Biologic Drugs Market Forecast (2018-2025)

11.2.2.2. France Biologic Drugs Market Forecast (2018-2025)

11.2.2.3. UK Biologic Drugs Market Forecast (2018-2025)

11.2.2.4. Russia Biologic Drugs Market Forecast (2018-2025)

11.2.2.5. Italy Biologic Drugs Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Biologic Drugs Market Forecast (2018-2025)

11.2.3.      Asia-Pacific Biologic Drugs Market Forecast (2018-2025)

11.2.3.1. China Biologic Drugs Market Forecast (2018-2025)

11.2.3.2. Japan Biologic Drugs Market Forecast (2018-2025)

11.2.3.3. Korea Biologic Drugs Market Forecast (2018-2025)

11.2.3.4. India Biologic Drugs Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Biologic Drugs Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Biologic Drugs Market Forecast (2018-2025)

11.2.4.      South America Biologic Drugs Market Forecast (2018-2025)

11.2.4.1. Brazil Biologic Drugs Market Forecast (2018-2025)

11.2.4.2. Argentina Biologic Drugs Market Forecast (2018-2025)

11.2.4.3. Columbia Biologic Drugs Market Forecast (2018-2025)

11.2.4.4. Rest of South America Biologic Drugs Market Forecast (2018-2025)

11.2.5.      Middle East and Africa Biologic Drugs Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Biologic Drugs Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Biologic Drugs Market Forecast (2018-2025)

11.2.5.3. Egypt Biologic Drugs Market Forecast (2018-2025)

11.2.5.4. Nigeria Biologic Drugs Market Forecast (2018-2025)

11.2.5.5. South Africa Biologic Drugs Market Forecast (2018-2025)

11.2.5.6. Turkey Biologic Drugs Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Biologic Drugs Market Forecast (2018-2025)

11.3. Biologic Drugs Market Forecast by Therapeutic Protein (2018-2025)

11.3.1.      Biologic Drugs Forecast by Therapeutic Protein (2018-2025)

11.3.2.      Biologic Drugs Market Share Forecast by Therapeutic Protein (2018-2025)

11.4. Biologic Drugs Market Forecast by Monoclonal Antibody (2018-2025)

11.4.1.      Biologic Drugs Forecast by Monoclonal Antibody (2018-2025)

11.4.2.      Biologic Drugs Market Share Forecast by Monoclonal Antibody (2018-2025)

11.5. Biologic Drugs Market Forecast by Vaccine  (2018-2025)

11.5.1.      Biologic Drugs Forecast by Vaccine  (2018-2025)

11.5.2.      Biologic Drugs Market Share Forecast by Vaccine  (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Biologic Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Biologic Drugs Revenue and Revenue Share by Therapeutic Protein (2014-2018)
Figure Global Betaseron Revenue and Growth Rate (2014-2018)
Figure Global Levemir Revenue and Growth Rate (2014-2018)
Figure Global Aranesp Revenue and Growth Rate (2014-2018)
Figure Global Humalog Revenue and Growth Rate (2014-2018)
Figure Global Neulasta Revenue and Growth Rate (2014-2018)
Figure Global Epogen Revenue and Growth Rate (2014-2018)
Figure Global Neupogen Revenue and Growth Rate (2014-2018)
Figure Global Eylea Revenue and Growth Rate (2014-2018)
Figure Global Avonex Revenue and Growth Rate (2014-2018)
Figure Global Rebif Revenue and Growth Rate (2014-2018)
Figure Global Enbrel Revenue and Growth Rate (2014-2018)
Figure Global Victoza Revenue and Growth Rate (2014-2018)
Figure Global Lantus Revenue and Growth Rate (2014-2018)
Figure Global NovoLog Revenue and Growth Rate (2014-2018)
Table Global Biologic Drugs Revenue and Revenue Share by Monoclonal Antibody (2014-2018)
Figure Global Remicade Revenue and Growth Rate (2014-2018)
Figure Global Humira Revenue and Growth Rate (2014-2018)
Figure Global Avastin Revenue and Growth Rate (2014-2018)
Figure Global Lucentis Revenue and Growth Rate (2014-2018)
Figure Global Herceptin Revenue and Growth Rate (2014-2018)
Figure Global Rituxan Revenue and Growth Rate (2014-2018)
Table Global Biologic Drugs Revenue and Revenue Share by Vaccine (2014-2018)
Figure Global Varivax Revenue and Growth Rate (2014-2018)
Figure Global Fluzone Revenue and Growth Rate (2014-2018)
Figure Global Gardasil Revenue and Growth Rate (2014-2018)
Figure Global Cervarix Revenue and Growth Rate (2014-2018)
Figure Global Prenvar 13 Revenue and Growth Rate (2014-2018)
Table Global Biologic Drugs Revenue by Regions (2014-2018)
Figure North America Biologic Drugs Growth Rate (2014-2018)
Figure North America Biologic Drugs Revenue and Growth Rate (2014-2018)
Figure North America Biologic Drugs by Countries (2014-2018)
Figure North America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)
Figure United States Biologic Drugs Growth Rate (2014-2018)
Figure United States Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Biologic Drugs Growth Rate (2014-2018)
Figure Canada Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Biologic Drugs Growth Rate (2014-2018)
Figure Mexico Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Biologic Drugs Growth Rate (2014-2018)
Figure Europe Biologic Drugs Revenue and Growth Rate (2014-2018)
Figure Europe Biologic Drugs by Countries (2014-2018)
Figure Europe Biologic Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Germany Biologic Drugs Growth Rate (2014-2018)
Figure Germany Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Biologic Drugs Growth Rate (2014-2018)
Figure France Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Biologic Drugs Growth Rate (2014-2018)
Figure UK Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Biologic Drugs Growth Rate (2014-2018)
Figure Russia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Biologic Drugs Growth Rate (2014-2018)
Figure Italy Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Biologic Drugs Growth Rate (2014-2018)
Figure Rest of Europe Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Biologic Drugs Growth Rate (2014-2018)
Figure Asia-Pacific Biologic Drugs Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Biologic Drugs by Countries (2014-2018)
Figure Asia-Pacific Biologic Drugs Revenue (Million USD) by Countries (2014-2018)
Figure China Biologic Drugs Growth Rate (2014-2018)
Figure China Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Biologic Drugs Growth Rate (2014-2018)
Figure Japan Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Biologic Drugs Growth Rate (2014-2018)
Figure Korea Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Biologic Drugs Growth Rate (2014-2018)
Figure India Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Biologic Drugs Growth Rate (2014-2018)
Figure Southeast Asia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Biologic Drugs Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Biologic Drugs Growth Rate (2014-2018)
Figure South America Biologic Drugs Revenue and Growth Rate (2014-2018)
Figure South America Biologic Drugs by Countries (2014-2018)
Figure South America Biologic Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Biologic Drugs Growth Rate (2014-2018)
Figure Brazil Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Biologic Drugs Growth Rate (2014-2018)
Figure Argentina Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Biologic Drugs Growth Rate (2014-2018)
Figure Columbia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Biologic Drugs Growth Rate (2014-2018)
Figure Rest of South America Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Biologic Drugs Growth Rate (2014-2018)
Figure Middle East and Africa Biologic Drugs Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Biologic Drugs by Countries (2014-2018)
Figure Middle East and Africa Biologic Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Biologic Drugs Growth Rate (2014-2018)
Figure Saudi Arabia Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Biologic Drugs Growth Rate (2014-2018)
Figure United Arab Emirates Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Biologic Drugs Growth Rate (2014-2018)
Figure Egypt Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Biologic Drugs Growth Rate (2014-2018)
Figure Nigeria Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Biologic Drugs Growth Rate (2014-2018)
Figure South Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Biologic Drugs Growth Rate (2014-2018)
Figure Turkey Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Biologic Drugs Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Biologic Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Table Abbott Laboratories Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Plc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Co. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Co. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Baxter International Inc. Biologic Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biologic Drugs Market Share by Manufacturer
Figure Global Biologic Drugs Revenue and Market Share by Manufacturer
Table Global Biologic Drugs Price by Region (2016-2017)
Figure Top 5 Biologic Drugs Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Biologic Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Biologic Drugs Market Forecast by Regions (2018-2025)
Figure North America Biologic Drugs Market Forecast (2018-2025)
Figure United States Biologic Drugs Market Forecast (2018-2025)
Figure Canada Biologic Drugs Market Forecast (2018-2025)
Figure Mexico Biologic Drugs Market Forecast (2018-2025)
Figure Europe Biologic Drugs Market Forecast (2018-2025)
Figure Germany Biologic Drugs Market Forecast (2018-2025)
Figure France Biologic Drugs Market Forecast (2018-2025)
Figure UK Biologic Drugs Market Forecast (2018-2025)
Figure Russia Biologic Drugs Market Forecast (2018-2025)
Figure Italy Biologic Drugs Market Forecast (2018-2025)
Figure Rest of Europe Biologic Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Biologic Drugs Market Forecast (2018-2025)
Figure China Biologic Drugs Market Forecast (2018-2025)
Figure Japan Biologic Drugs Market Forecast (2018-2025)
Figure Korea Biologic Drugs Market Forecast (2018-2025)
Figure India Biologic Drugs Market Forecast (2018-2025)
Figure Southeast Asia Biologic Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Biologic Drugs Market Forecast (2018-2025)
Figure South America Biologic Drugs Market Forecast (2018-2025)
Figure Brazil Biologic Drugs Market Forecast (2018-2025)
Figure Argentina Biologic Drugs Market Forecast (2018-2025)
Figure Columbia Biologic Drugs Market Forecast (2018-2025)
Figure Rest of South America Biologic Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Biologic Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Biologic Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Biologic Drugs Market Forecast (2018-2025)
Figure Egypt Biologic Drugs Market Forecast (2018-2025)
Figure Nigeria Biologic Drugs Market Forecast (2018-2025)
Figure South Africa Biologic Drugs Market Forecast (2018-2025)
Figure Turkey Biologic Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Biologic Drugs Market Forecast (2018-2025)
Figure Global Biologic Drugs Forecast by Therapeutic Protein (2018-2025)
Figure Global Biologic Drugs Market Share Forecast by Therapeutic Protein (2018-2025)
Figure Global Biologic Drugs Forecast by Therapeutic Protein (2018-2025)
Figure Global Biologic Drugs Forecast by Monoclonal Antibody (2018-2025)
Figure Global Biologic Drugs Market Share Forecast by Monoclonal Antibody (2018-2025)
Figure Global Biologic Drugs Forecast by Monoclonal Antibody (2018-2025)
Figure Global Biologic Drugs Forecast by Vaccine (2018-2025)
Figure Global Biologic Drugs Market Share Forecast by Vaccine (2018-2025)
Figure Global Biologic Drugs Forecast by Vaccine (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*